Studies have shown that BRCA1 P/LP variant positive patients present with high-grade disease, compared to BRCA2 P/LP variant positive patients and with sporadic/non-hereditary cases of breast cancer [59–65]. This evidence concerns the gene BRCA1 and breast carcinoma.